Schedule 13G Filing for Ideaya Biosciences Inc.

This filing is an amendment to a Schedule 13G filed by The Vanguard Group, Inc. regarding Ideaya Biosciences Inc. The amendment, dated March 27, 2026, indicates a change in reporting for beneficial ownership. Due to an internal realignment on January 12, 2026, certain subsidiaries of The Vanguard Group, Inc. will now report beneficial ownership separately. The filing states that The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries. The reported ownership for The Vanguard Group, Inc. is 0 shares, with 0% ownership, and the same for sole and shared voting and dispositive power. The filing also notes that while The Vanguard Group, including its managed accounts, has the right to dividends and sale proceeds, no single person has more than a 5% interest.